Property:Results after intervention
This is a property of type Text.
L
Lua et al. (2015): Effects of inhaled ginger aromatherapy on chemotherapy-induced nausea and vomiting and health-related quality of life in women with breast cancer +
Quality of life:
* Total score (day 8 of chemotherapy): Intervention-arm significantly superior MD 4.44, 95%CI 1.13 to 7.76, p<0.001
Subcategories (day 8 of chemotherapy), intervention-arm significantly superior in terms of:
* Role function: MD 1.94, 95%CI -5.35 to 9.24, p=0.001
* Fatigue: MD -3.15, 95%CI -8.06 to 1.77, p=0.002
* Nausea / vomiting: MD -3.61, 95%CI -7.51 to 0.29, p<0.001
* Pain: MD -2.78, 95%CI -6.59 to 1.03, p=0.017
* Loss of appetite: MD -6.67, 95%CI -12.50 to -0.83, p<0.001
* Constipation: MD -1.67, 95%CI -6.25 to 2.92, p=0.046
* Effect of role function and loss of appetite clinically relevant (10 point difference) +
Lua et al. (2015): Effects of inhaled ginger aromatherapy on chemotherapy-induced nausea and vomiting and health-related quality of life in women with breast cancer +
NA +
Lua et al. (2015): Effects of inhaled ginger aromatherapy on chemotherapy-induced nausea and vomiting and health-related quality of life in women with breast cancer +
NA +
Lyckholm et al. (2012): A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders +
NI +
M
Mahmoodnia et al. (2017): Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients +
Mean (SD), p-Wert of interaction between time and arm:
significant different development in arms; values in lycopene arm tend to remain the same, values in control arm fall/get worse:
Lycopene arm start: 66.67 (18.75), day 7: 69.22 (20.28), day 21: 67.14 (20.10)
Control arm start: 72.06 (17.39), day 7: 71.92 (17.17), day 21: 65.01 (20.77), p=0.004, significant +
Mahmoodnia et al. (2017): Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients +
Mean (SD), p-Wert of interaction between time and arm:
no significant differences in arms:
Lycopene arm start: 1.05 (0.23), day 7: 1.12 (0.65), day 21: 1.09 (0.42)
Control arm start: 1.00 (0.24), day 7: 1.00 (0.22), day 21: 1.17 (0.51), p=0.131, not significant +
Mahmoodnia et al. (2017): Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients +
Mean (SD), p-value of the interaction between time and arm:
significantly different development of the arms; values in lycopene arm fall/improve considerably from start of the study to day 7, but then rise again almost to the initial level at day 21
Values in control arm tend to increase/decrease slightly
Lycopene arm start: 29.29 (9.25), day 7: 16.17 (8.97), day 21: 26.82 (9.27)
Control arm start: 26.62 (9.80), day 21: 25.55 (7.72), day 21: 30.74 (11.65), p<0.001, significant +
Mansouri et al. (2016): The Effect of Aloe Vera Solution on Chemotherapy-Induced Stomatitis in Clients with Lymphoma and Leukemia: A Randomized Controlled Clinical Trial +
No significant difference was found between the two arms with respect to the mean intensity of stomatitis
and pain on day 1, but a significant difference was observed in this regard on days 3 to 14. +
Mansouri et al. (2016): The Effect of Aloe Vera Solution on Chemotherapy-Induced Stomatitis in Clients with Lymphoma and Leukemia: A Randomized Controlled Clinical Trial +
No significant difference was found between the two arms with respect to the mean intensity of stomatitis
and pain on day 1, but a significant difference was observed in this regard on days 3 to 14. +
Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer +
NA +
Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer +
NA +
Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer +
NA +
Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer +
NA +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
NA +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
NA +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
NA +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
NA +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
NA +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
NA +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
No sign. difference between arms (p=NI) +